Insider trading

Period: 120 months Stock: CRSP Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

89 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

89 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

89 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

89 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
89 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
89 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

89 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
6 Oct 2026
KASINGER JAMES R. General Counsel and Secretary
Sold on a plan
$119.48K 1,990 at 60.04
2.1%
Planned (10b5-1)
22 Sep 2026
KASINGER JAMES R. General Counsel and Secretary
Sold on a plan
$626.46K 10,400 at 60.24
9.9%
Planned (10b5-1)
29 May 2026
Patel Naimish Chief Medical Officer
Sold at will
$210.58K 3,786 at 55.62
16.4%
Not planned
23 Mar 2026
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$148.85K 3,182 at 46.78
3.3%
Not planned
16 Mar 2026
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$166.50K 3,450 at 48.26
3.6%
Not planned
16 Mar 2026
Patel Naimish Chief Medical Officer
Sold at will
$152.02K 3,150 at 48.26
19.3%
Not planned
11 Mar 2026
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$147.84K 2,800 at 52.80
3.1%
Not planned
19 Feb 2026
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$111.05K 2,112 at 52.58
2.4%
Not planned
14 Oct 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$71.66K 1,076 at 66.60
1.3%
Not planned
29 May 2025
Patel Naimish Chief Medical Officer
Sold at will
$141.32K 3,932 at 35.94
39.3%
Not planned
3 Apr 2025
Patel Naimish Chief Medical Officer
Bought
$49.70K 1,508 at 32.96
opened
First buy on file
21 Mar 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$131.32K 3,185 at 41.23
3.8%
Not planned
21 Mar 2025
Bruno Julianne Chief Operating Officer
Sold at will
$70.67K 1,714 at 41.23
14.0%
Not planned
12 Mar 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$48.35K 1,116 at 43.32
1.4%
Not planned
12 Mar 2025
Bruno Julianne Chief Operating Officer
Sold at will
$8.23K 190 at 43.32
2.2%
Not planned
11 Mar 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$120.90K 2,850 at 42.42
3.5%
Not planned
11 Mar 2025
Bruno Julianne Chief Operating Officer
Sold at will
$50.82K 1,198 at 42.42
12.7%
Not planned
19 Feb 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$102.80K 1,947 at 52.80
2.5%
Not planned
19 Feb 2025
Bruno Julianne Chief Operating Officer
Sold at will
$17.58K 333 at 52.80
4.5%
Not planned
18 Feb 2025
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$516.69K 9,595 at 53.85
11.6%
Not planned
14 Oct 2024
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$50.40K 1,089 at 46.28
1.7%
Not planned
21 Jun 2024
Bruno Julianne Chief Operating Officer
Sold at will
$188.80K 3,366 at 56.09
33.3%
Not planned
12 Mar 2024
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$85.31K 1,146 at 74.44
1.8%
Not planned
11 Mar 2024
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$219.21K 2,801 at 78.26
4.5%
Not planned
20 Feb 2024
KASINGER JAMES R. General Counsel and Secretary
Sold at will
$152.41K 1,913 at 79.67
3.2%
Not planned
30 Jun 2021
Novak Rodger President
Sold, plan not stated
$4.13M 25,000 at 165.00
4.2%
28 Jun 2021
Novak Rodger President
Sold, plan not stated
$3.91M 25,000 at 156.55
4.0%
21 Jun 2021
Novak Rodger President
Sold, plan not stated 6×
$3.22M 25,000 at 128.62
3.9%
23 Mar 2021
Sold, plan not stated 2×
$12.81M 100,000 at 128.05
99.0%
Sold half or more
19 Jan 2021
KASINGER JAMES R. General Counsel and Secretary
Sold, plan not stated 5×
$5.64M 27,500 at 204.94
55.1%
Sold half or more
15 Jan 2021
Sold, plan not stated 13×
$5.38M 25,000 at 215.20
55.6%
Sold half or more
21 Dec 2020
Ho Tony W Executive VP, Head of R&D
Sold, plan not stated 9×
$3.51M 23,551 at 149.23
40.9%
30 Nov 2020
Novak Rodger President
Sold, plan not stated 2×
$12.50M 100,000 at 125.00
13.4%
9 Oct 2020
Novak Rodger President
Sold, plan not stated
$276.20K 2,762 at 100.00
0.4%
8 Oct 2020
Novak Rodger President
Sold, plan not stated
$2.22M 22,238 at 100.00
3.3%
1 Sep 2020
Novak Rodger President
Sold, plan not stated 3×
$2.32M 25,000 at 92.62
3.7%
19 Aug 2020
Novak Rodger President
Sold, plan not stated
$2.50M 25,000 at 100.00
3.7%
7 Jul 2020
Novak Rodger President
Sold, plan not stated
$2.25M 25,000 at 90.00
3.7%
1 Jul 2020
Novak Rodger President
Sold, plan not stated
$4.00M 50,000 at 80.00
7.2%
25 Jun 2020
Sold, plan not stated
$369.27K 4,912 at 75.18
19.7%
24 Jun 2020
Sold, plan not stated 7×
$4.94M 65,088 at 75.93
76.5%
Sold half or more
23 Jun 2020
Novak Rodger President
Sold, plan not stated
$3.75M 50,000 at 75.00
6.7%
23 Jun 2020
Ho Tony W Executive VP, Head of R&D
Sold, plan not stated
$521.06K 6,929 at 75.20
17.0%
22 Jun 2020
Ho Tony W Executive VP, Head of R&D
Sold, plan not stated
$16.06K 229 at 70.14
0.6%
26 May 2020
Novak Rodger President
Sold, plan not stated
$2.57M 36,616 at 70.27
4.7%
26 May 2020
Ho Tony W Executive VP, Head of R&D
Sold, plan not stated
$427.85K 6,100 at 70.14
13.0%
22 May 2020
Novak Rodger President
Sold, plan not stated
$937.01K 13,384 at 70.01
1.7%
22 May 2020
Ho Tony W Executive VP, Head of R&D
Sold, plan not stated
$42.03K 600 at 70.05
1.3%
19 May 2020
Novak Rodger President
Sold, plan not stated
$3.25M 50,000 at 65.00
5.9%
11 May 2020
Sold, plan not stated 2×
$1.51M 25,000 at 60.40
55.6%
Sold half or more
Showing 1–50 of 89. Page 1 of 2 Older →